Skip to content

Insider · CIK 0001879947

Oleg Movchan

ceoofficerdirectorowner

Files at ENFN (Enfusion, Inc.). First filing Jan 10, 2025, latest Mar 7, 2025.

Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 3
$0 bought, $191k sold

Signals

This insider’s open-market buys and sells, scored.

ScoreCompanyValueHoldingsPrice contextFiled
51Moderate
ENFNsell 6
Enfusion, Inc.
$130k
11,452 shares
-2%-
45Moderate
ENFNsell 6
Enfusion, Inc.
$32k
2,790 shares
-0%-
45Moderate
ENFNsell 6
Enfusion, Inc.
$28k
2,771 shares
-1%-

Transactions

Every row this insider has filed, newest first.

DateCompanyTransactionSharesPriceValueHoldings afterFiled
Apr 21, 2025ENFN
Enfusion, Inc.
DDisposition to issuer
Class A Common Stockindirect: By CSL Tech Holdings, LLC
-1,151,818--0Apr 21, 2025
Apr 21, 2025ENFN
Enfusion, Inc.
DDisposition to issuer
Class A Common Stock
-51,808--580,039Apr 21, 2025
Apr 21, 2025ENFN
Enfusion, Inc.
DDisposition to issuer
Class A Common Stock
-230,039--350,000Apr 21, 2025
Apr 21, 2025ENFN
Enfusion, Inc.
DDisposition to issuer
Class A Common Stock
-250,000--100,000Apr 21, 2025
Apr 21, 2025ENFN
Enfusion, Inc.
DDisposition to issuer
Class A Common Stock
-100,000--0Apr 21, 2025
Mar 6, 2025ENFN
Enfusion, Inc.
SOpen-market sale
Class A Common Stock
-11,452$11.39$130k631,847Mar 7, 2025
Mar 3, 2025ENFN
Enfusion, Inc.
SOpen-market sale
Class A Common Stock
-2,790$11.48$32k643,299Mar 5, 2025
Feb 26, 2025ENFN
Enfusion, Inc.
AGrant or award
Class A Common Stock
+110,230$0.00$0636,932Feb 28, 2025
Feb 26, 2025ENFN
Enfusion, Inc.
AGrant or award
Class A Common Stock
+9,157$0.00$0646,089Feb 28, 2025
Jan 7, 2025ENFN
Enfusion, Inc.
SOpen-market sale
Class A Common Stock
-2,771$10.13$28k526,702Jan 10, 2025

Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.

Oleg Movchan: insider trades and track record | InsiderTell